Highlights from the 2002 Digestive Disease Week. Best of DDW 2002

Nimish Vakil; Robert H. Hawes; Stephen B. Hanauer; Martin L. Freeman; Michael Camilleri

Highlights from the 2002 Digestive Disease Week. Best of DDW 2002

Nimish Vakil, Robert H. Hawes, Stephen B. Hanauer, Martin L. Freeman, Michael Camilleri

Medicine - Gastro, Hepatology, Nutrition Division

Research output: Contribution to journal › Article › peer-review

Abstract

In the presentations reviewed above, there is clearly a trend toward using flexible endoscopes to perform procedures that have heretofore been seen as "surgeries." Although it is exciting to see these developments, we should be reminded that new techniques and technologies must be carefully evaluated by well-designed clinical trials before being integrated into general practice, and the drive and incentive for adopting them into our clinical practice should be the results of good science rather than Wall Street hype.

Original language	English (US)
Pages (from-to)	126-141
Number of pages	16
Journal	Reviews in gastroenterological disorders
Volume	2
Issue number	3
State	Published - Jun 1 2002

Keywords

Azathioprine
Barrett's esopagus
Cancer staging
Crohn's disease
Endoscopic retrograde cholangiopancreatography
Endoscopy
Gastric bypass
Gastroesophageal reflux disease
Ghrelin
H. pylori
Inflammatory bowel disease
Infliximab
Leptin
Obesity
Orexin
Resistance, antimicrobial
Satiation
Sphincter of Oddi manometry
Stents, pancreatic
Training, endoscopic
Triple therapy
Ultrasound, endoscopic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Find It

Find It at U of M Libraries

Cite this

@article{df8fbe5588fb42d796ef8f3abbc75eb5,

title = "Highlights from the 2002 Digestive Disease Week. Best of DDW 2002",

abstract = "In the presentations reviewed above, there is clearly a trend toward using flexible endoscopes to perform procedures that have heretofore been seen as {"}surgeries.{"} Although it is exciting to see these developments, we should be reminded that new techniques and technologies must be carefully evaluated by well-designed clinical trials before being integrated into general practice, and the drive and incentive for adopting them into our clinical practice should be the results of good science rather than Wall Street hype.",

keywords = "Azathioprine, Barrett's esopagus, Cancer staging, Crohn's disease, Endoscopic retrograde cholangiopancreatography, Endoscopy, Gastric bypass, Gastroesophageal reflux disease, Ghrelin, H. pylori, Inflammatory bowel disease, Infliximab, Leptin, Obesity, Orexin, Resistance, antimicrobial, Satiation, Sphincter of Oddi manometry, Stents, pancreatic, Training, endoscopic, Triple therapy, Ultrasound, endoscopic",

author = "Nimish Vakil and Hawes, {Robert H.} and Hanauer, {Stephen B.} and Freeman, {Martin L.} and Michael Camilleri",

year = "2002",

month = jun,

day = "1",

language = "English (US)",

volume = "2",

pages = "126--141",

journal = "Reviews in gastroenterological disorders",

issn = "1533-001X",

publisher = "MedReviews LLC",

number = "3",

}

TY - JOUR

T1 - Highlights from the 2002 Digestive Disease Week. Best of DDW 2002

AU - Vakil, Nimish

AU - Hawes, Robert H.

AU - Hanauer, Stephen B.

AU - Freeman, Martin L.

AU - Camilleri, Michael

PY - 2002/6/1

Y1 - 2002/6/1

N2 - In the presentations reviewed above, there is clearly a trend toward using flexible endoscopes to perform procedures that have heretofore been seen as "surgeries." Although it is exciting to see these developments, we should be reminded that new techniques and technologies must be carefully evaluated by well-designed clinical trials before being integrated into general practice, and the drive and incentive for adopting them into our clinical practice should be the results of good science rather than Wall Street hype.

AB - In the presentations reviewed above, there is clearly a trend toward using flexible endoscopes to perform procedures that have heretofore been seen as "surgeries." Although it is exciting to see these developments, we should be reminded that new techniques and technologies must be carefully evaluated by well-designed clinical trials before being integrated into general practice, and the drive and incentive for adopting them into our clinical practice should be the results of good science rather than Wall Street hype.

KW - Azathioprine

KW - Barrett's esopagus

KW - Cancer staging

KW - Crohn's disease

KW - Endoscopic retrograde cholangiopancreatography

KW - Endoscopy

KW - Gastric bypass

KW - Gastroesophageal reflux disease

KW - Ghrelin

KW - H. pylori

KW - Inflammatory bowel disease

KW - Infliximab

KW - Leptin

KW - Obesity

KW - Orexin

KW - Resistance, antimicrobial

KW - Satiation

KW - Sphincter of Oddi manometry

KW - Stents, pancreatic

KW - Training, endoscopic

KW - Triple therapy

KW - Ultrasound, endoscopic

UR - http://www.scopus.com/inward/record.url?scp=0036595787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036595787&partnerID=8YFLogxK

M3 - Article

C2 - 12227216

AN - SCOPUS:0036595787

SN - 1533-001X

VL - 2

SP - 126

EP - 141

JO - Reviews in gastroenterological disorders

JF - Reviews in gastroenterological disorders

IS - 3

ER -

Highlights from the 2002 Digestive Disease Week. Best of DDW 2002

Abstract

Keywords

UN SDGs

Find It

Other files and links

Fingerprint

Cite this